Author

Vivek Kumar

National Institutes of HealthORCID 0000-0001-7536-9281Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Vivek Kumar2 papers · Carnegie Mellon University

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Amy Hauck NewmaniD· 1 shared Benedict James KolberiD· 1 shared Christian Kuete FofiéiD· 1 shared Eduardo J. E. Caro‐DiaziD· 1 shared Freja HerborgiD· 1 shared Henrik Berg RasmusseniD· 1 shared Jesus E. Sotelo-Morales· 1 shared Jonatan Fullerton StøieriD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Amy Hauck NewmanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NeuroscienceJournal of Natural ProductsPeer-reviewedNov 6, 2025

Neurobiological and Chemical Characterization of the Cyanobacterial Metabolite Veraguamide E

Jesus E. Sotelo-Morales, Sahar Mofidi Tabatabaei, Christian Kuete Fofié…·Kevin Joseph Tidgewell

This paper characterizes the cyanobacterial metabolite Veraguamide E, showing it binds the sigma-2 receptor with high affinity, modulates calcium signaling in neurons, and lacks cytotoxicity.

5 citations

humanproteomics

𝕏 PostBluesky

Genetic & Genomic MedicinemedRxivPreprintAug 29, 2023

Disruptive mutations in the serotonin transporter associate serotonin dysfunction with treatment-resistant affective disorder

Jonatan Fullerton Støier, Trine Nygaard Jørgensen, Thomas Sparsø…·Freja Herborg

The paper identifies two disruptive SERT variants in treatment-resistant affective disorder patients and shows they cause partial loss-of-function, with one variant responsive to pharmacochaperoning.

4 citations

humanstatistical model

𝕏 PostBluesky